Home
/
Vitamin-D

Vitamin D3 vs. D2: Why the Form You Take Matters

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 31, 2026
Last updated
May 30, 2026
Key takeaway:

Vitamin D3 and D2 both raise 25-hydroxyvitamin D levels, but they are not interchangeable. Research shows D3 is approximately 87% more potent than D2 at raising and sustaining serum levels, and D3 has a circulation half-life of 3 to 4 weeks versus 2 to 3 weeks for D2. Prescription formulas commonly use D2, but for daily supplementation, D3 — including vegan lichen-derived versions — consistently outperforms D2 in clinical trials.

Read more →
Table of contents

You've probably seen both vitamin D2 and D3 on supplement labels and wondered if the difference matters. It does. Both forms will technically raise your vitamin D levels, but they don't behave the same way once they're in your body. One is absorbed more efficiently, stays in circulation longer, and produces a more sustained rise in the marker that actually reflects your vitamin D status. The other is cheaper to manufacture and often marketed as equivalent, but the evidence tells a different story.

Knowing whether you're deficient in vitamin D starts with testing the right marker. Superpower's baseline panel measures 25-hydroxyvitamin D, the form that reflects total body stores, alongside the cofactors like magnesium that determine how well your body can activate and use what you're taking.

Key Takeaways

  • Vitamin D3 raises 25-hydroxyvitamin D levels more effectively than D2 in most clinical trials.
  • D3 has a longer half-life in circulation, sustaining vitamin D status for weeks longer.
  • D2 is plant-derived and vegan, while D3 traditionally comes from animal sources like lanolin.
  • The body converts both forms to 25-hydroxyvitamin D, but D3 does so more efficiently.
  • D2 is often used in prescription formulations despite being less potent per dose.
  • Vegan D3 from lichen is now available and performs similarly to animal-derived D3.
  • Testing 25-hydroxyvitamin D is the only way to know if your supplementation is working.

What Vitamin D2 and D3 Actually Are

Vitamin D isn't a single molecule. It's a family of compounds that share a similar structure but differ in where they come from and how the body processes them. Vitamin D2 (ergocalciferol) is produced when ultraviolet light hits ergosterol, a sterol found in fungi and yeast. Vitamin D3 (cholecalciferol) is what your skin synthesizes when exposed to UVB radiation, and it's also the form found in animal tissues like fatty fish, egg yolks, and liver.

Both D2 and D3 are biologically inactive when you ingest them. They require two hydroxylation steps to become active. The first occurs in the liver, converting them to 25-hydroxyvitamin D, the major circulating form and the marker clinicians test to assess vitamin D status. The second hydroxylation happens primarily in the kidneys, producing 1,25-dihydroxyvitamin D, the hormonally active form that regulates calcium absorption, immune function, and gene expression.

The structural difference between D2 and D3 is subtle but consequential:

  • D2 has a double bond in its side chain and an extra methyl group.
  • These changes affect how tightly the molecule binds to vitamin D-binding protein in the blood.
  • They influence how efficiently it's converted to 25-hydroxyvitamin D.
  • They determine how quickly it's cleared from circulation.

The result is that equal doses of D2 and D3 do not produce equal increases in serum 25-hydroxyvitamin D.

What the Clinical Trials Actually Show

The difference isn't trivial. Some studies have found D3 to be approximately 87% more potent than D2 in raising and maintaining serum 25-hydroxyvitamin D levels (2023 meta-analysis). This shorter half-life matters clinically because D2 supplementation requires more frequent dosing to maintain stable levels.

Not every study has found D3 superior. A few trials, particularly those using very high intermittent doses, have reported similar efficacy between the two forms. But these are the exception, and most were limited by small sample sizes or short follow-up periods. Most available evidence suggests D3 is more effective than D2 at raising and maintaining serum 25(OH)D levels over time.

How D2 and D3 Behave Differently in the Body

The difference in potency between D2 and D3 comes down to binding affinity, conversion efficiency, and metabolic stability. Vitamin D3 binds more tightly to vitamin D-binding protein, the carrier molecule that transports vitamin D through the bloodstream. This tighter binding protects D3 from degradation and extends its circulation time. D2 binds more loosely, making it more vulnerable to clearance by the liver and kidneys.

The liver enzyme that converts vitamin D to 25-hydroxyvitamin D (CYP2R1) also appears to favor D3 as a substrate. While both forms are hydroxylated, D3 is converted more efficiently, producing higher circulating levels of 25-hydroxyvitamin D per unit of intake. This difference becomes especially pronounced at lower doses, where the enzyme's preference for D3 is more evident.

D2 also has a shorter half-life in circulation, typically lasting 2 to 3 weeks compared to D3's 3 to 4 weeks. This means that even if you achieve the same peak level with D2, it won't last as long. For people taking weekly or monthly doses, this difference translates to more variable vitamin D status with D2 compared to D3.

Dose, Form, and Timing

Dose

Most clinical guidelines recommend 600 to 800 IU of vitamin D daily for adults to maintain sufficiency, with higher doses used to correct deficiency. Because D3 is more potent, a given dose of D3 will raise 25-hydroxyvitamin D levels more than the same dose of D2. Prescription vitamin D2, often given as 50,000 IU weekly, compensates for this lower potency with a much larger dose. For repletion, daily dosing with D3 is generally more effective than intermittent high-dose D2, producing more stable 25-hydroxyvitamin D levels without the peaks and troughs seen with weekly or monthly dosing.

Form

Vitamin D2 is inherently vegan because it's derived from yeast or mushrooms exposed to UV light. Traditional D3 comes from lanolin (sheep's wool) or fish oil, but lichen-derived vegan D3 is now widely available and performs equivalently. Vitamin D is fat-soluble, so absorption improves when taken with a meal containing fat. Some formulations use oil-based capsules or emulsified preparations to enhance bioavailability, but the form of vitamin D itself matters more than the delivery vehicle.

Timing

Vitamin D doesn't need to be taken at a specific time of day, but taking it with your largest meal (which typically contains the most fat) optimizes absorption. Because it's fat-soluble, it doesn't compete with water-soluble vitamins for absorption, so timing relative to other supplements is less critical. The exception is magnesium, which is required for the enzymes that activate vitamin D. If you're supplementing both, taking them together makes mechanistic sense.

Who Benefits Most from D3, and Who Should Be Careful

Anyone with documented vitamin D deficiency benefits from supplementation, and D3 is the more efficient choice for most people. Deficiency is especially common in individuals with limited sun exposure, darker skin pigmentation, obesity, malabsorption disorders, or chronic kidney disease. Older adults also absorb and synthesize vitamin D less efficiently, making supplementation more important with age.

Vegans and vegetarians have historically relied on D2 because D3 was only available from animal sources. With the availability of lichen-derived D3, this is no longer a barrier. Vegan D3 performs as well as animal-derived D3 and is a better choice than D2 for maintaining stable vitamin D levels.

People taking high-dose vitamin D should monitor their calcium levels. Vitamin D increases intestinal calcium absorption, and excessive intake can lead to hypercalcemia, particularly in individuals with granulomatous diseases like sarcoidosis or in those taking thiazide diuretics. Symptoms of vitamin D toxicity include:

  • Nausea and vomiting
  • Weakness and fatigue
  • Kidney stones
  • Confusion and disorientation

The tolerable upper intake level for adults is 4,000 IU daily, though toxicity is rare below 10,000 IU daily when taken chronically (2023 meta-analysis). Individuals with chronic kidney disease require careful monitoring because impaired renal hydroxylation reduces the conversion of 25-hydroxyvitamin D to its active form. These patients may need active vitamin D analogs rather than standard D2 or D3 supplementation.

Testing Your Vitamin D Status

The only way to know if your vitamin D supplementation is working is to measure 25-hydroxyvitamin D. This is the marker that reflects total body stores and predicts long-term sufficiency. Serum 25-hydroxyvitamin D levels below 20 ng/mL indicate deficiency, 20 to 30 ng/mL is considered insufficient, and levels above 30 ng/mL are generally regarded as sufficient. Functional medicine practitioners often target 40 to 60 ng/mL for optimal health, though the evidence supporting higher targets is less robust (2025 literature review).

Testing is especially important if you're taking D2, because its shorter half-life and lower potency mean your levels may not be as stable as you think. A single test doesn't tell you much about variability. If you're on weekly or monthly dosing, testing at different points in the dosing cycle can reveal whether you're experiencing significant peaks and troughs.

Vitamin D status doesn't exist in isolation. Magnesium is required for the enzymes that convert vitamin D to its active form, and magnesium deficiency can blunt your response to supplementation. Calcium and vitamin K also interact with vitamin D in bone metabolism and vascular health. Testing these markers together gives a more complete picture of whether your supplementation strategy is working and whether cofactor deficiencies are limiting your response.

Getting a Real Picture of Your Vitamin D Status

Most people supplementing vitamin D have never tested their 25-hydroxyvitamin D levels, which means they're dosing blind. You don't know if you're deficient, if your dose is adequate, or if the form you're taking is actually raising your levels. Superpower's baseline panel measures 25-hydroxyvitamin D alongside the cofactors that determine how well your body can activate and use it, including magnesium, calcium, and markers of bone and metabolic health. Testing before you start supplementing establishes your baseline. Testing again after 8 to 12 weeks tells you whether your dose and form are working, or whether you need to adjust.

FAQs

D2 (ergocalciferol) has a double bond in its side chain and an extra methyl group compared to D3 (cholecalciferol). These structural differences cause D2 to bind more loosely to vitamin D-binding protein in the blood, making it more vulnerable to clearance by the liver and kidneys. D2 is also converted to 25-hydroxyvitamin D less efficiently by the liver enzyme CYP2R1. Together, these differences give D3 a longer half-life — 3 to 4 weeks versus 2 to 3 weeks — and roughly 87% greater potency at the same dose.

The liver enzyme CYP2R1 hydroxylates both D2 and D3 into 25-hydroxyvitamin D, but it binds D3 more efficiently as a substrate. The structural differences in D2's side chain — specifically the extra double bond and methyl group — reduce how well it fits the enzyme's active site. This means a greater proportion of each D3 dose gets converted to the circulating form that labs measure, while more D2 is cleared before conversion. The difference is most pronounced at lower supplementation doses.

Prescription vitamin D2 became standard largely for historical reasons — D2 was the first synthetic form available and was used in fortification programs for decades. Regulatory familiarity and manufacturing economics kept it in prescription use. Prescribers compensate for its lower potency with a much larger dose, typically 50,000 IU weekly. However, this creates peaks and troughs in serum levels that daily D3 dosing avoids. Clinical evidence increasingly favors D3 for achieving stable, sustained 25-hydroxyvitamin D levels.

Yes. Lichen-derived vegan D3 (cholecalciferol) is chemically identical to animal-derived D3 and performs equivalently in clinical studies. Both raise serum 25-hydroxyvitamin D levels with the same efficiency and share the same half-life and binding affinity. This makes lichen-derived D3 the preferred choice for vegans and vegetarians over D2, which has historically been the only plant-based option but is less potent and less consistent at maintaining stable vitamin D levels.

The clearest sign is a 25-hydroxyvitamin D test result that remains below your target range after 8 to 12 weeks of consistent supplementation. Other clues include persistent fatigue, frequent illness, bone pain, or muscle weakness — symptoms associated with low vitamin D — that do not improve despite supplementation. If you are taking D2 on a weekly schedule, testing at different points in the dosing cycle can reveal whether levels are fluctuating widely, which may indicate the form or frequency of dosing needs adjustment.

People with obesity are at high risk because vitamin D is fat-soluble and sequesters in adipose tissue, reducing its bioavailability even with adequate intake. Those with malabsorption conditions — celiac disease, Crohn's disease, or gastric bypass — absorb less from the gut regardless of dose or form. Individuals with chronic kidney disease cannot efficiently hydroxylate 25-hydroxyvitamin D into its active form and may need active vitamin D analogs. Darker skin pigmentation also slows synthesis, making dietary and supplemental sources more critical year-round.

References

  1. van den Heuvel, E. G., Lips, P., Schoonmade, L. J., Lanham-New, S. A., & van Schoor, N. M. (2024). Comparison of the Effect of Daily Vitamin D2 and Vitamin D3 Supplementation on Serum 25-Hydroxyvitamin D Concentration (Total 25(OH)D, 25(OH)D2, and 25(OH)D3) and Importance of Body Mass Index: A Systematic Review and Meta-Analysis. Advances in nutrition (Bethesda, Md.), 15(1), 100133. https://doi.org/10.1016/j.advnut.2023.09.016
  2. Zittermann, A., Trummer, C., Theiler-Schwetz, V., & Pilz, S. (2023). Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials. European journal of nutrition, 62(4), 1833-1844. https://doi.org/10.1007/s00394-023-03124-w
  3. Grant, W. B., Wimalawansa, S. J., Pludowski, P., & Cheng, R. Z. (2025). Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines. Nutrients, 17(2). https://doi.org/10.3390/nu17020277

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey